Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rajet Vatsa"'
Autor:
Melody Huang, Alba Gutiérrez-Sacristán, Elizabeth Janiak, Katherine Young, Anabel Starosta, Katherine Blanton, Alaleh Azhir, Caroline N. Goldfarb, Felícita Kuperwasser, Kimberly M. Schaefer, Rachel E. Stoddard, Rajet Vatsa, Allison A. Merz-Herrala, Deborah Bartz
Publikováno v:
Contraception and Reproductive Medicine, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract Background Information on social media may affect peoples’ contraceptive decision making. We performed an exploratory analysis of contraceptive content on Twitter (recently renamed X), a popular social media platform. Methods We selected a
Externí odkaz:
https://doaj.org/article/73ad8858d60948b39a7046adc7a48bde
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Randomized trials are considered the gold standard for making inferences about the causal effects of treatments. However, when protocol deviations occur, the baseline randomization of the trial is no longer sufficient to ensure un
Externí odkaz:
https://doaj.org/article/31b41b2d1f184844a697703bb755ea9c
Autor:
Katia C. Genadry, Christine Shrock, Delia O'Shea, Rajet Vatsa, Ankoor S. Shah, Ryan Gise, Susan C. Lipsett
Publikováno v:
The Journal of emergency medicine. 61(6)
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-9 (2019)
Trials
Trials
Background Randomized trials are considered the gold standard for making inferences about the causal effects of treatments. However, when protocol deviations occur, the baseline randomization of the trial is no longer sufficient to ensure unbiased es
Technical details of the IP weighted estimation algorithm and comparison of bias calculation using a single large sample versus average of many small samples. (PDF 166 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61e3814483d94c8e84983a1da5fb401
Autor:
Kara L. Curley, Rajet Vatsa, Eric C. Woolf, Adrienne C. Scheck, Julie A. Charlton, Claire J. Woodrow
Publikováno v:
Neuro-Oncology. 16:v93-v93
Patients with malignant gliomas have a median survival of approximately 15 months following diagnosis, regardless of currently available treatments which include surgery, radiation and chemotherapy. Improvement in the survival of these patients requi